PURPOSE: To describe the patient characteristics and clinical course of an unusual reticular pattern of bullous epithelial corneal edema in a series of patients treated with netarsudil. DESIGN: Retrospective case series. METHODS: Case series at a single academic center wherein treatment with netarsudil produced a particular pattern of bullous epithelial corneal edema. RESULTS: 6 episodes of reticular bullous epithelial corneal edema were identified in 5 eyes of 5 patients treated with netarsudil. 4 of 5 patients had a history of corneal edema in the affected eye, and the fifth patient had risk factors for corneal edema including a history of anterior uveitis and an anterior chamber glaucoma drainage device. In 4 of 6 episodes, corneal edema was present, typically in the corneal stroma, at the time of netarsudil initiation. In 5 of 6 cases, visual acuity worsened with onset of bullous epithelial edema, and in all cases visual acuity stabilized or improved following discontinuation of netarsudil. In all cases, the reticular bullous epithelial edema improved or resolved after discontinuation of netarsudil. CONCLUSIONS: We report the patient characteristics and natural history of a particular pattern of reticular bullous epithelial edema in a series of patients treated with netarsudil once daily. Most patients had a history of corneal edema or predisposing risk factors for corneal edema. All patients demonstrated improvement in bullous epithelial edema after netarsudil discontinuation. Visual acuity improved in most patients within weeks after discontinuation of netarsudil, although two patients also underwent surgical interventions that may have contributed to improved visual acuity.
PURPOSE: To describe the patient characteristics and clinical course of an unusual reticular pattern of bullous epithelial corneal edema in a series of patients treated with netarsudil. DESIGN: Retrospective case series. METHODS: Case series at a single academic center wherein treatment with netarsudil produced a particular pattern of bullous epithelial corneal edema. RESULTS: 6 episodes of reticular bullous epithelial corneal edema were identified in 5 eyes of 5 patients treated with netarsudil. 4 of 5 patients had a history of corneal edema in the affected eye, and the fifth patient had risk factors for corneal edema including a history of anterior uveitis and an anterior chamber glaucoma drainage device. In 4 of 6 episodes, corneal edema was present, typically in the corneal stroma, at the time of netarsudil initiation. In 5 of 6 cases, visual acuity worsened with onset of bullous epithelial edema, and in all cases visual acuity stabilized or improved following discontinuation of netarsudil. In all cases, the reticular bullous epithelial edema improved or resolved after discontinuation of netarsudil. CONCLUSIONS: We report the patient characteristics and natural history of a particular pattern of reticular bullous epithelial edema in a series of patients treated with netarsudil once daily. Most patients had a history of corneal edema or predisposing risk factors for corneal edema. All patients demonstrated improvement in bullous epithelial edema after netarsudil discontinuation. Visual acuity improved in most patients within weeks after discontinuation of netarsudil, although two patients also underwent surgical interventions that may have contributed to improved visual acuity.
Authors: Maria A Guzman Aparicio; Daniel L Liebman; James Chodosh; Suzanne K Freitag; Melanie Kazlas; Derek D Mai; Catherine M Marando; Shizuo Mukai; Annie M Wu; Teresa C Chen Journal: Am J Ophthalmol Case Rep Date: 2022-06-28
Authors: Jennifer A Tran; Ula V Jurkunas; Jia Yin; Emma C Davies; David A Sola-Del Valle; Teresa C Chen; Michael M Lin Journal: Am J Ophthalmol Case Rep Date: 2022-01-20
Authors: Sarah R Michalak; Soohyun Kim; Sangwan Park; M Isabel Casanova; Morgan A W Bowman; Michelle Ferneding; Brian C Leonard; Kathryn L Good; Jennifer Y Li; Sara M Thomasy Journal: Transl Vis Sci Technol Date: 2022-09-01 Impact factor: 3.048